Northern Trust Corp Sorrento Therapeutics, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$0.74 - $1.83 $550,020 - $1.36 Million	743,271 Added 21.62%	4,180,871 $3.72 Million
Q3 2022 Nov 14, 2022	SELL	$1.51 - $2.88 $18,933 - $36,112	-12,539 Reduced 0.36%	3,437,600 $5.4 Million
Q2 2022 Aug 12, 2022	BUY	$1.24 - $2.33 $785,169 - $1.48 Million	633,201 Added 22.48%	3,450,139 $6.93 Million
Q1 2022 May 13, 2022	SELL	$2.0 - $4.9 $257,000 - $629,650	-128,500 Reduced 4.36%	2,816,938 $6.56 Million
Q4 2021 Feb 08, 2022	BUY	$4.65 - $7.23 $133,352 - $207,341	28,678 Added 0.98%	2,945,438 $13.7 Million
Q3 2021 Nov 15, 2021	BUY	$7.41 - $10.99 $459,294 - $681,193	61,983 Added 2.17%	2,916,760 $22.3 Million
Q2 2021 Aug 13, 2021	BUY	$6.35 - $10.0 $681,221 - $1.07 Million	107,279 Added 3.9%	2,854,777 $27.7 Million
Q1 2021 May 12, 2021	SELL	$7.03 - $16.51 $1.04 Million - $2.45 Million	-148,419 Reduced 5.13%	2,747,498 $22.7 Million
Q4 2020 Feb 11, 2021	BUY	$5.76 - $11.95 $1.39 Million - $2.88 Million	240,852 Added 9.07%	2,895,917 $19.8 Million
Q3 2020 Nov 16, 2020	BUY	$6.17 - $18.82 $2.28 Million - $6.96 Million	369,586 Added 16.17%	2,655,065 $29.6 Million
Q2 2020 Aug 14, 2020	BUY	$1.73 - $6.76 $1.14 Million - $4.46 Million	659,608 Added 40.57%	2,285,479 $14.4 Million
Q1 2020 May 14, 2020	BUY	$1.57 - $4.76 $65,938 - $199,915	41,999 Added 2.65%	1,625,871 $2.99 Million
Q4 2019 Feb 14, 2020	BUY	$1.45 - $4.17 $126,946 - $365,079	87,549 Added 5.85%	1,583,872 $5.35 Million
Q3 2019 Nov 13, 2019	BUY	$2.05 - $2.69 $297,526 - $390,413	145,135 Added 10.74%	1,496,323 $3.2 Million
Q2 2019 Aug 13, 2019	BUY	$2.67 - $4.38 $46,004 - $75,467	17,230 Added 1.29%	1,351,188 $3.61 Million
Q1 2019 May 13, 2019	BUY	$1.86 - $5.94 $136,633 - $436,346	73,459 Added 5.83%	1,333,958 $6.34 Million
Q4 2018 Feb 12, 2019	SELL	$2.01 - $4.24 $58,263 - $122,904	-28,987 Reduced 2.25%	1,260,499 $3.03 Million
Q3 2018 Nov 14, 2018	BUY	$4.22 - $7.5 $1.21 Million - $2.14 Million	285,836 Added 28.48%	1,289,486 $5.67 Million
Q2 2018 Sep 18, 2018	BUY	$4.75 - $8.0 $211,769 - $356,664	44,583 Added 4.65%	1,003,650 $7.23 Million
Q2 2018 Aug 14, 2018	BUY	$4.75 - $8.0 $3.81 Million - $6.42 Million	802,965 Added 514.38%	959,067 $6.91 Million
Q1 2018 May 09, 2018	BUY	$4.5 - $9.95 $95,166 - $210,422	21,148 Added 15.67%	156,102 $804,000
Q4 2017 Feb 14, 2018	SELL	$1.75 - $3.8 $68,902 - $149,617	-39,373 Reduced 22.59%	134,954 $513,000
Q3 2017 Nov 13, 2017	BUY	$1.63 - $2.0 $284,153 - $348,654	174,327	174,327 $297,000

Others Institutions Holding SRNE

# of Institutions

Shares Held

5.47M

Call Options Held

Put Options Held

View Full List

About Sorrento Therapeutics, Inc.

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

More about SRNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account